2023 for LGP, page-27

Having a nibble here as I think this company is positioned and well timed to take advantage of an enormous but yet to be properly realised aussie market. In time, maybe years, when the wheels of politics have turned to reflect the needs of the people, then I'm gambling there may be a return on an investment here. The early signs are showing in the political world. People want "natural" pain (physical and psychological) relief. Inverted commas as its likely fed a NPK cocktail for quality control. As the next generation continues to wake up to the sins of big pharma, demand will grow, as the boomers influence shrinks and the indoctrination of fear of the 'devils weed' becomes the shrill of those that should be using it most, shifting sentiment will eventually result in a profitable LGP. I'm sure Gina will bring in the top talent when the time is right.